Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1916.3000 5.10 (0.27%)
NSE Aug 24, 2026 14:37 PM
Volume: 215.7K
High vol.+gain this week

logo
Ipca Laboratories Ltd.
14 Oct 2024
1916.30
0.27%
buy
by Motilal Oswal
Target: 1950
Motilal Oswal
After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.
 
Number of FII/FPI investors increased from 246 to 256 in Jun 2026 qtr.
More from Ipca Laboratories Ltd.
Recommended
Market trades lower, Oriental Hotels to merge with IHCL
Trendlyne Marketwatch | 24 Aug 2026, 01:59PM
Five Interesting Stocks Today - August 21, 2026
The Baseline | 21 Aug 2026
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021